MLH1 and prostate carcinoma: It has been reported that MLH1 polymorphisms correlate with the pathogenesis of colorectal cancer, lung cancer, breast cancer, prostate cancer, head and neck squamous cell carcinoma, and oral squamous cell carcinoma29–36.